High school senior helps the Maine Parkinson Society

We recently ran a notice in the Upcoming Events section of Maine PD News about a fundraiser to support the Maine Parkinson Society (MEPS).  The event raised money by sale of movie tickets at Smitty’s Cinema in Topsham on the 27th of October.

Cameron Loeschner, a senior at Mount Ararat High School, organized the event.  He tells me this was a part of his capstone project.   Thinking of his grandfather, Cameron noted, “I wanted to do something that would benefit Parkinson’s disease.”  Seniors work with a mentor on the capstone, and Cameron reports his mentor was Amy Berube, LMSW  at Mid Coast-Parkview Health.  “We worked together, looked up different ideas, and came up with a movie night.”  They raised over $620 and donated it MEPS.  “I didn’t know much about Maine Parkinson’s at first, but I wanted to have more of a direct impact on my community.  Amy helped me with selecting them, and I contacted Morgan Knox.  Morgan was a big part of it.”

The event apparently went well, and Cameron says, “I’m, glad I did it.  To be the one that set that up was really cool.  It made me see what I want to do in life, and it felt really good to do something that may help my grandfather.

James Pope, Cameron’s grandfather, tells me “I am very proud of Cameron for spotlighting something this close to home.  It means a lot that he thought of me, and that he kept the money right here in Maine.  There are all kinds of programs around the country, but very few right here in our state.”

Cameron has been accepted to Thomas College, in Waterville, Maine, and plans to major in communications with a concentration in public relations and marketing.   He’s off to a good start.   Thank you, Cameron!

 

Maine Parkinson Society Fundraiser Thursday, October 27, 2016

parkinson-fundraiser-flyer

Support the Maine Parkinson Society by seeing a movie at Smitty’s Cinema at 65 Topsham Fair Mall Road, Topsham, Maine.   Print out the flyer in the link above, take the coupon to any showing on 10/27/16, and half of your $10 admission price will benefit MEPS.   The event is being organized by a senior at Mt Ararat High School as a part of his capstone project, and is a tribute to his grandfather, a PD sufferer.

PD Pearls

pearl NYPL digital image

Manganese toxicity does not cause PD, but may cause a static, unchanging parkinsonism.

The “Parkinson personality” is one of avoiding risk, caffeine, nicotine, and alcoholism, and is often present for many years prior to the onset of the motor symptoms of PD.  

PD can occur at any age, but is most common in older people.  Based on U.S. Census Bureau count of the number of Mainers over 65 and over 80 in 2015, along with the incidence of PD as people age, one can estimate at least 3500 elderly Mainers currently have PD.

“ON” time is when medications are working and symptoms are lessened.  

“OFF” time is when medications are not working and symptoms are present or worse.

Dietary Supplements

It is estimated that over 50% of U.S. citizens use a daily supplement, whether an herbal, plant-based, amino acid, or a vitamin.  Many PD patients take one or more of these compounds.  My experience is that there is often an assumption that these products are natural, and therefore good for you, and the supply in stores is safe because the FDA will protect us from harmful substances.  These points should be taken separately.

 Are supplements good for you?

The issue is complex.  Some might be, and some are not.  Consider vitamins, for example. Vitamins are by definition required for health, but for the vast majority of us vitamin supplements are not necessary because we get the very small amounts we need from foods in a healthy diet.  Most of the time, if a person does not have a documented vitamin deficiency, taking over the counter vitamins does not improve health at all.  In fact, many well-designed studies involving hundreds of thousands of people have found no evidence that vitamins prevent heart disease, dementia, or cancers (1-3).  Experts in medicine have called for patients to stop taking unnecessary vitamins (4).  Thus, taking a vitamin to “make sure” you have enough in your system is not recommended.  Complicating matters, there are studies indicating PD patients may be deficient of vitamins B6, B12, and D.  And, there is marketing all around telling consumers to take vitamins.   The best approach is, if indicated, for a qualified doctor to check a level and advise you on whether or not you should take a vitamin.  If taking a vitamin for a specific medical reason, stick to the dose directed by the doctor.  There are certain medical conditions that may call for a period of taking a higher than normal dose of a vitamin. However, in general, taking a “more is better” approach may lead to serious health problems, especially when one takes megadoses (doses many times larger than usual or recommended).  Some vitamins may actually be toxic in high doses commonly available in stores. Vitamin B6 toxicity can cause neuropathy or dermatitis.   Acute vitamin D toxicity may cause confusion, excess urination, excess thirst, loss of appetite, vomiting, and muscle weakness. Chronically high levels of vitamin D may result in kidney stones, loss of bone mineralization, and pain. Vitamin E supplementation was found to be unhelpful for PD in the DATATOP trial of the 1990s, and is also known to be associated with health risks.  A meta-analysis (a review of multiple studies) including nearly 136,000 people showed that use of vitamin E in doses at or above 400IU daily may increase all causes of death (5). The bottom line: take vitamins only if directed by a doctor familiar with the guidelines.

And vitamins are not the only supplements.    The use of CoQ10 is widespread, though in a large, multi-center trial by the Parkinson Study Group, the supplement showed no clinical benefit (6).  In other words, it did not help symptoms or improve scores on PD rating scales. CoQ10 also did not slow down disease, as had been hoped. Similar negative results have been shown in trials of CoQ10 for several other neurologic diseases.

Plants hold a vast potential for medicine. Plant-based supplements however, are not always effective, and some may interact with or block the effect of prescription medications.  Some plant or herb supplements may cause harm. Nature is potent, and produces trees that can be used to make chemotherapy, bark that can be made into aspirin, and clover that is used to make the blood thinner warfarin, to name just a few.  Doctors know that these products are potentially as dangerous as they are helpful.  For example, the molecules used to make warfarin are also used as a poison found in pesticides.  When used as a medicine warfarin has to be adjusted very carefully.  The same care should be taken with any ingested compound, especially if there is the potential for danger. Simply designating a supplement safe because it comes from a plant is a dangerous and irrational position.   For example, the supplement kava (extracted from the pepper plant Piper methysticum), may actually worsen PD symptoms, and if combined with the drug alprazolam, may result in a coma-like state (7). There are many other examples.   Plants have had millions of years to evolve defenses against animals, some of which are very complex.  Plants are potent for good and bad, and that is about as natural as you can get.   This is one very important reason why it is important to make sure the compounds you take are safe.

Does the FDA protect us from harmful substances getting into supplements?

The FDA does not necessarily protect us from the potential dangers of supplements.  By federal law, they are actually quite limited in this regard.  To be clear, it was Congress which defined vitamins and other supplements as “dietary supplements” in 1994 (8), restricted the FDA, and created a law in which the supplement industry was to police itself.   To quote the FDA (9):

“The U.S. Food and Drug Administration (FDA) does not have the authority to review dietary supplement products for safety and effectiveness before they are marketed.  The manufacturers and distributors of dietary supplements are responsible for making sure their products are safe before they go to market.”

Why is there a law preventing the FDA from regulating supplements?

In 1993, Dr. David Kessler, then commissioner of the FDA, attempted to regulate supplements.  He was quoted in the June 15, 1993 edition of the New York Times to say, “The dietary supplement industry is pushing hard for deregulation of their products…There are no assurances that these products are appropriately manufactured, that what’s on the label is actually in the bottle, that they bear adequate directions for use to insure safety or that basic safety data has been collected and reviewed” (10).  This was in the face of numerous cases of injury or death resulting from the use of supplements.  However, according to Dr. Kessler on the program Frontline, January 2016 (11), “What happened was the dietary supplement industry recognized that the standard that we set — significant scientific agreement — would require it, before it could make a claim, to have a scientific basis.  And they just couldn’t make any claim.  And they saw, literally, billions of dollars at stake, and they unleashed a lobbying campaign that was second to none.”  This included a national television commercial (12) presenting the FDA in a fictitious middle-of-the-night, special ops-style raid on the home of actor Mel Gibson because he had a bottle of vitamin C.  The commercial included dark lighting, ominous sound effects, and a voice over with Mel urging, “If you don’t want to lose your vitamins, make the FDA stop.  Call the U.S. Senate and tell them you want to take your vitamins in peace.” The commercial ended with a written instruction to “Protect your right to use vitamins and other supplements. Write Congress Now.”  Several other actors spoke out publically, making similar straw man arguments, and Americans seemed to side with them, rather than the federal agency staffed with scientists and doctors, which had been established to protect them.   The call to action by those with no medical or scientific training, along with organized efforts in health food stores around the country, resulted in massive letter writing.  Per Frontline, Congress received over two million letters on this topic. In 1994, Congress passed the Dietary Supplements Health and Education Act (DSHEA), which limited then, and continues to limit now, the FDA as above.  The key author was Senator Orin Hatch of Utah.  According to author Dan Hurley in his 2006 book Natural Causes (13), supplements were the focus of Utah’s third leading industry, Hatch owned over 35,000 shares of stock in a company that manufactured supplements, and Hatch’s son was a lobbyist for the supplement industry.  Hatch was further noted to be the recipient of large campaign contributions from the supplement industry dating back to the 1980s.

 Is anyone evaluating supplements?

Federal laws restricting the FDA have not stopped independent investigators from analyzing supplements to see if they truly contain what their labels state.   Multiple studies have shown outright substitution of herbal supplements in which the product contains something other than the stated substance (14,15), and whatever is actually in the supplement is not listed. Other studies have demonstrated that traditional supplements manufactured overseas may contain contaminants including toxic heavy metals such as lead, mercury, and arsenic (16-22).  The U.S. manufacture of supplements containing these toxins has also been demonstrated (23).  Per the World Health Organization (24) “It is well known that there are many contaminants and residues that may cause harm to the consumers of herbal medicines.”  There are many reports in which prescription drugs have been added to supplements without reporting this on the label.  Thus, it is of the utmost importance to make sure that the product one is using is safe.  How that will happen is unclear.   Experts call for reform and proper oversight of the supplement industry (25).  Writers in lay press point to the lack of oversight and the politics behind the DSHEA law in less flattering terms (26, 27).   Consumer Reports (CR) dedicated its September 16, 2016 issue to supplements and safety.  The article “Supplements, a complete guide to safety,” notes, “Pills and capsules make promises they can’t keep in a marketplace with a profound lack of oversight.”  The article notes that since DSHEA became law, supplement products have grown in number from about 4,000 in 1994 to over 90,000 today.  CR cites an industry currently generating $40 billion a year.

But this is a safe supplement, right?

Finally, many patients tell me that they believe some supplement is superior because a healthcare provider sold it to them directly in the office.   The American Medical Association (AMA) Code of Physician Conduct (28) notes that the sale of health-related products by physicians raises ethical concerns about financial conflict of interest, undue pressure on the patient, erosion of trust, undermining of the primary obligation of physicians to serve the interests of their patients before their own, and such sales “demean the profession of medicine.”  The Maine Board of Licensure in Medicine also reflects this language.

References   (URLS accessed in August and early September, 2016)

  1. Fortmann, et al. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013; 159:824-34.
  2.  Grodstein, et al. Long-term multivitamin supplementation and cognitive function in men. A randomized trial. Ann Intern Med. 2013; 159:806-14.
  3.  Lin, et al. Screening for cognitive impairment in older adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013; 159:601-12.
  4. Guallar, et al. Enough Is Enough: Stop Wasting Money on Vitamin and Mineral Supplements. Ann Intern Med. 2013;159:850-851   http://annals.org/article.aspx?articleid=1789253 .
  5. Miller, et al.  Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med.  2005;142(1):37-46.
  6. Beal, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014;71(5):543-52.
  7. Izzo A, Ernst E.  Interactions between herbal medicines and prescribed drugs: a systematic review.  Drugs. 2001;61(15):2163-75.
  8. http://www.fda.gov/food/dietarysupplements/usingdietarysupplements/ucm480069.htm#
  9.  http://www.fda.gov/Food/DietarySupplements/UsingDietarySupplements/ucm109760.htm
  10. http://www.nytimes.com/1993/06/15/us/fda-is-again-proposing-to-regulate-vitamins-and-supplements.html
  11. http://www.pbs.org/wgbh/frontline/film/supplements-and-safety/transcript/       The segment Supplements and Safety may be watched at  http://www.pbs.org/wgbh/frontline/film/supplements-and-safety/
  12. https://www.youtube.com/watch?v=IV2olDA0w8U
  13. Hurley, Dan. p76.  Natural Causes.  2006, Broadway Books, New York, New York.   A thorough and well-referenced history of the history of the interaction between the FDA and the supplement industry, including the passage of the DSHEA law.
  14. de Boer, et al. DNA Barcoding and Pharmacovigilance of Herbal Medicines.  Drug Saf. 2015;38(7):611-20.
  15. Parvathy, et al.  Detection of plant-based adulterants in turmeric powder using DNA barcoding.  Pharm Biol. 2015;53(12):1774-9.
  16. Saper, et al.  Heavy Metal Content of Ayurvedic Herbal Medicine Products. Jama 2004;292(23):2868-2873.
  17. Gair. Heavy Metal Poisoning  from Ayurvedic Medicines. BCMJ. 2008;50(2):105
  18. Gogtay, et al. The use and safety of non-allopathic Indian medicines. Drug Safety 2002;25:1005-1019.
  19. Lynch, et al. A review of the clinical and toxicological aspects of ‘traditional’ (herbal) medicines adulterated with heavy metals. Expert Opin Drug Saf 2005;4:769-778.
  20.  Kumar, et al. Unique Ayurvedic metallic-herbal preparations, chemical characterization. Biol Trace Elem Res 2006;109:231-254.
  21. Centers for Disease Control and Prevention (CDC). Lead poisoning associated with Ayurvedic medications—five states, 2000–2003. MMWR. 2004;53:582-584.
  22.  Breeher et al. A cluster of lead poisoning among consumers of Ayurvedic medicine International Journal of Occupational 304 and Environmental Health2015;21(4):304-7.
  23. Saper et al.  Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the Internet JAMA. 2008;300(8): 915–923.
  24. WHO Guidelines for assessing quality of herbal medicines with reference to contaminants and residues.  2007  http://apps.who.int/medicinedocs/documents/s14878e/s14878e.pdf
  25. Starr R. Should states and local governments regulate dietary supplements? Drug Test Anal. 2016;8(3-4):402-6.
  26.  http://www.nytimes.com/2015/02/06/opinion/the-politics-of-fraudulent-dietary-supplements.html?_r=0
  27. http://www.nytimes.com/2013/11/05/science/herbal-supplements-are-often-not-what-they-seem.html?pagewanted=all&_r=0
  28. AMA Code of Medical Ethics

B6, friend or foe?

Pyridoxine, also known as vitamin B6, is a supplement that many people take, either by itself or in a multivitamin.  It is available over the counter, no prescription required.  Most of the patients taking B6 with whom I have spoken, however, have very little idea what B6 does, and other than a general recommendation they have been given at some point, are not very clear about whether they should take it at all.

It is true that B6 deficiency can lead to illness.  It is also true that taking too much B6 can be dangerous.   Here, I am going to briefly explain the basics of B6 and take apart the common issues PD patients may face with this vitamin.

B6 is classified as a coenzyme.  Coenzymes are small molecules that assist enzymes in chemical reactions.  There are thousands upon thousands of these reactions going on all the time in your body.   B6 is involved in over 100 enzyme reactions with proteins, amino acids, carbohydrates, and lipids.  B6 helps to maintain homocysteine levels in the blood; is a participant in immune function; and is involved the development of cognition through the formation of neurotransmitters – those chemicals like dopamine that allow one nerve to communicate with another.   Deficiency of B6 is therefore associated with many different conditions such as anemia, dermatitis, cheilosis (scaling of lips, and cracks at the corners of the mouth), immune dysfunction, glossitis (swollen tongue), confusion, irritability, seizures, neuropathy, and depression.  In short, it is important to have normal B6 levels.

We get B6 by eating a healthy diet.  It is found in fruits, grains, fish, poultry, beef liver and other organ meats, potatoes, and some other starchy vegetables.  Absorbing nutrients from foods is not always easy, however, and this leads some to think that they should supplement B6 and other vitamins to “make sure” they are getting enough.  This should not be done blindly.

It is true that some vitamins and minerals are absorbed by a special process, which may take several steps in the body.  A failure of any one of the multiple biochemical steps required may cause poor absorption of the vitamin, and thus a deficiency.  This is the case with B12, for example, but it is not the case for B6.   B6 is absorbed passively in the jejunum, a part of the small bowel.  When a vitamin is absorbed passively, absorption is not an energy-requiring process, and when one has good health, there is usually no obstacle to B6 moving freely into the blood stream.  It would therefore seem easy to maintain a normal level of B6 in the body.

However, a small percentage of people will have B6 deficiency for a variety of reasons, such as kidney disease; celiac disease, Crohn’s disease, ulcerative colitis, and other malabsorption syndromes; autoimmune disease such as rheumatoid arthritis; alcohol dependence; and exposure to certain medications such as antiepileptic drugs.   There is some data, also, that PD patients who take large amounts of levodopa may have low B6 levels (1, 2).  Most of that data comes from European case reports of patients receiving continuous carbidopa/levodopa infusion via the Duodopa pump (not to be confused with Duopa in the United States), but it is also known that PD patients taking high doses of oral carbidopa/levodopa have a higher prevalence of chronic, sensory, axonal polyneuropathy (3), in other words, nerve damage.  It should be noted that some studies point to a deficiency of B12 in these patients, and apparently B6 was not always measured.   There is mounting evidence for both. It is not entirely clear how a B6 deficiency is happening in these patients.  One possible mechanism involves carbidopa, which is meant to block an enzyme in the body called dopamine decarboxylase, so that levodopa makes it to the brain.  However, carbidopa also inhibits the action of B6.  It may also be that absorption of B6 is somehow blocked by carbidopa/levodopa, or that downstream biochemical reactions deplete B6 and B12.  According to the prescribing information of carbidopa/levodopa (Sinemet), B6 and carbidopa/levodopa may be given safely together (4).  Though there is no formal guideline recommending testing, it has been suggested by some authors that it might be worthwhile to check one’s blood level, especially if one is taking moderate to high doses of levodopa, or suffering from any of the above-mentioned disease states (1).  Anecdotally, in my clinic I have diagnosed multiple PD patients taking carbidopa/levodopa with B6 deficiencies, where no other clear cause is evident.

The good news is that measuring a B6 level is done with a simple blood test, and replacement may be given with over-the-counter tablets.  However, as with any supplement or medication, care should be taken in replacing B6, and to be clear, I re-emphasize that I am not recommending anyone take a B6 supplement without knowing one’s own blood level first.  Ideally, a qualified physician should interpret the test and tell you whether you need B6 supplementation, and if so, how much you should take.  The United States Recommended Daily Allowance (USRDA) daily dose for men over 50 is 1.7mg, and for women of the same age 1.5mg (5).   In most individuals, this amount is readily obtainable with consumption of a healthy diet. Higher doses are sometimes recommended for short periods, for specific conditions.  You should know that many over the counter vitamin supplements carry amounts of B6 that are far higher than this, sometimes into or over the 500% or “megadose” range.  The Food Intake Board of the Institute of Medicine has established that for men or women over 50, the tolerable daily upper intake level of B6 is 100 mg (6), a dose commonly found in grocery stores.  B6 at this dose is 59 times higher than USRDA for women and 67 times higher than USRDA for men.

Overdosing B6 can be dangerous for several reasons.  Merck Pharmaceuticals has stated that B6 in doses of 10 mg to 25 mg may actually reverse the effects of levodopa by increasing the rate of the enzyme activity that carbidopa is meant to inhibit (4).  In other words, levodopa is depleted in the body before it can get to the brain, where it is needed to work against PD.   There is no mention of the effect on the same enzyme when B6 is given at 100, 500, even 1000mg (all doses which are available in some health food, drug, and grocery stores), though one would suspect it is even more potent in driving down levodopa, and thus worsening the symptoms of PD.  In addition, much like the case when B6 levels in the body are too low, excess B6 is well documented to cause neuropathy, or nerve damage, as well as a disfiguring skin condition ( 7, 8,9). The Weill Cornell Neuropathy Center evaluated all new neuropathy consultations from July 2014 until June 2015 and found that 7% had elevated B6 levels; whereas only 1.5% combined had either B6, or B12 deficiencies (10). Among the total group studied abnormal levels of nutritional factors were implicated in 24%. Likewise, the Peripheral Neuropathy Center at Columbia University evaluated patients over a 10 year period ending in 2012 (11). These were new referrals with an existing diagnosis of idiopathic neuropathy, meaning another physician, typically a neurologist, had not yet determined the cause of the neuropathy. Among these patients, B6 toxicity accounted for 2.5%; whereas B6 deficiency was 0.3%, and B12 deficiency 1.4%.

In summary, some PD patients may have a high or low B6 level, and either may be harmful. There is some concern that carbidopa/levodopa may indirectly drive B6 levels down.  B6 supplements may contain doses that are far too strong for daily use, and toxicity has been linked to neuropathy, and possible negative impact on PD symptoms. If you have concerns about your B6 level, have a qualified doctor check your level and advise you about how and whether to take B6.

REFERENCES (online sources as of mid September, 2016)

1.  Müller et al. Peripheral neuropathy in Parkinson’s disease: levodopa exposure and implications for duodenal delivery.  Parkinsonism Relat Disord. 2013;19(5):501-7.

2.  Urban et al.  Subacute axonal neuropathy in Parkinson’s disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord. 2010;25(11):1748-52.

3. Uncini et al. Polyneuropathy associated with duodenal infusion of levodopa in Parkinson’s disease: features, pathogenesis and management.  J Neurol Neurosurg Psychiatry. 2015;86(5):490-5.

4. https://www.merck.com/product/usa/pi_circulars/s/sinemet/sinemet_pi.pdf

5.https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/

6.  http://www.nationalacademies.org/hmd/~/media/Files/Activity-Files/Nutrition/DRIs/New%20Material/4_%20UL%20Values_Vitamins%20and%20Elements.pdf

7. Schaumburg et al.  Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome.  N Engl J Med. 1983;309(8):445-448.

8. Barak N, Huminer D, Stahl B. Vitamin B6 (Pyridoxine) — excessive dosage in food supplements and OTC medications. Harefuah 2004;143(12):887-90, 910, 909.

9. de Kruijk JR, Notermans NC.  Sensory disturbances caused by multivitamin preparations. Ned Tijdschr Geneeskd. 2005;149(46):2541-2544.

10. Latov et al.  Abnormal nutritional factors in patients evaluated at a neuropathy center.  J Clin Neuromuscul Dis. 2016;17(4):212-214.

11. Farhad et al., Causes of Neuropathy In Patients Referred As “Idiopathic Neuropathy” Muscle Nerve 2016;53:856-861

Fall Issue

It is time for fall issue articles to be posted and we will ultimately place all content in a single .pdf for download.  I would like to thank contributing writers, the PD community in Maine, and Liz Stamey, BSN, RN, for stylistic and copy editing.

This issue will include:

Exercise in PD by Dr. Michael Kleinman

The Neuropsychological Evaluation by Dr. Thomas Miller

And other articles, involving Sinemet, vitamins, and supplements-common issues in the clinic.

Thanks for reading.

September, 2016 Events

9/6/16 (Tuesday) at 4pm     Bill Stamey, M.D. will be speaking about Steps People with Parkinson Disease Can Take for Better Health in the Wellness Rehab Conference Room, LincolnHealth, St. Andrews Campus, 6 St. Andrews Lane, Boothbay Harbor, ME 04538. 

____________________________________________________

9/10/26 (Saturday)     The New England Parkinson’s Ride, the Ballpark, Old Orchard Beach.

The New England Parkinson’s Ride


Several people in the Main PD community will be riding in the event and if you would like to sponsor one of us to raise money for the Michael J Fox Foundation, give online at:
Bill Stamey, M.D.   http://www2.michaeljfox.org/site/TR/Athletic/TeamFox?px=2491616&pg=personal&fr_id=1974
To select any of the several other riders at the Neuroscience Team at Maine Medical Center   http://www2.michaeljfox.org/site/TR/Athletic/TeamFox?pg=team&fr_id=1974&team_id=19700

_________________________________________________________

9/12/16 (Monday) 11am to noon     Bill Stamey, M.D. will give an Ounce of Prevention Lecture Series discussion about Parkinson disease at Mid Coast Senior Health Center, 58 Baribeau Drive, Brunswick in the Community Room. http://www.midcoastseniorhealthcenter.com/     207-373-3646

____________________________________________________________

9/27/16 (Tuesday) at 7pm      Our Health Film and Discussion Series, will be viewing the 2014 Sundance Film Festival award-winning documentary film ALIVE INSIDE     http://www.aliveinside.us/
Following the film there will be a discussion panel including:
-Tim Knight, R.N., Director of Clinical Services, Mid Coast Senior Health Center
-Florin Olteanu, M.D., C.M.D., Mid Coast Senior Health Center
-Bill Stamey, M.D., Mid Coast Medical Group Neurology
Frontier Cafe, Cinema, Gallery, 14 Maine Street, Mill 3, Fort Andross, Brunswick, Maine 04011. The evening requires reservations, which are free and can be reserved at: http://www.brownpapertickets.com/event/2592748

___________________________________________________________

9/20-23/16 (Tues-Friday)     World Parkinson’s Congress, Portland, Oregon, (yes, Oregon, not in Maine, but a unique meeting for physicians, scientists, and patients).
http://www.wpc2016.org/?gclid=Cj0KEQjwouW9BRCN0ozIifTI6_cBEiQAD9gNsSlWloKjPQSlm_okOYkDIQSxINL2CrG8Sc-5Qg9OjCoaAsMJ8P8HAQ

PD Pearls

pearl NYPL digital imageExcessive stomach acidity delays stomach emptying, thus delaying the absorption of levodopa.   Patients with gastritis, reflux, or chronic heartburn are at risk of other medical conditions as well, and should seek medical help.

Iron salts (such as in multivitamin tablets or ferrous sulfate tablets) may reduce the amount of levodopa available to the body. Iron salts can chelate levodopa and carbidopa, and therefore reduce the bioavailability and effectiveness of carbidopa/levodopa (Sinemet). If iron must be taken, it should not be given at the same time as carbidopa/levodopa.

Restless Leg syndrome (RLS) is a little more common among PD patients than the general population and tends to be worse at night.  Symptoms typically include a deep, uncomfortable sensation in the legs (not the feet), the urge to move, stretch, or walk, and at least partial relief with movement.  Some patients confuse these symptoms with wearing off of PD medications. Adding to the confusion, PD medications can relieve the symptoms, and therefore, wearing off might exacerbate RLS.

The incidence of PD: 1% over age 60, 4% over age 80.  In 2012, the U.S. Census Report estimated about 43,000,000 people over 65 in the U.S.  The Parkinson Disease Foundation estimates up to a million U.S. citizens have PD.